113 related articles for article (PubMed ID: 37332093)
1. Hyaluronan synthesis inhibition normalizes ethanol-enhanced hepatic stellate cell activation.
Kotulkar M; Robarts DR; Lin-Rahardja K; McQuillan T; Surgnier J; Tague SE; Czerwinski M; Dennis KL; Pritchard MT
Alcohol Clin Exp Res (Hoboken); 2023 Aug; 47(8):1544-1559. PubMed ID: 37332093
[TBL] [Abstract][Full Text] [Related]
2. 4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization.
Andreichenko IN; Tsitrina AA; Fokin AV; Gabdulkhakova AI; Maltsev DI; Perelman GS; Bulgakova EV; Kulikov AM; Mikaelyan AS; Kotelevtsev YV
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847129
[TBL] [Abstract][Full Text] [Related]
3. NAMPT-mediated NAD
Xu L; Yang C; Ma J; Zhang X; Wang Q; Xiong X
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S666-S675. PubMed ID: 34752167
[No Abstract] [Full Text] [Related]
4. Hyaluronan synthase 2, a target of miR-200c, promotes carbon tetrachloride-induced acute and chronic liver inflammation via regulation of CCL3 and CCL4.
Kim SM; Song GY; Shim A; Lee JH; Eom CB; Liu C; Yang YM; Seki E
Exp Mol Med; 2022 Jun; 54(6):739-752. PubMed ID: 35662287
[TBL] [Abstract][Full Text] [Related]
5. Differential recruitment of monocyte-derived macrophages in control and stellate cell-depleted mice during recurrent carbon tetrachloride-induced acute liver injury.
Sharma A; Kudira R; Wang J; Miethke A; Gandhi CR
J Cell Physiol; 2022 Nov; 237(11):4215-4225. PubMed ID: 36098042
[TBL] [Abstract][Full Text] [Related]
6. Moderate, chronic ethanol feeding exacerbates carbon-tetrachloride-induced hepatic fibrosis via hepatocyte-specific hypoxia inducible factor 1α.
Roychowdhury S; Chiang DJ; McMullen MR; Nagy LE
Pharmacol Res Perspect; 2014 Oct; 2(5):e00061. PubMed ID: 25089199
[TBL] [Abstract][Full Text] [Related]
7. Moderate (2%, v/v) Ethanol Feeding Alters Hepatic Wound Healing after Acute Carbon Tetrachloride Exposure in Mice.
Deshpande KT; Liu S; McCracken JM; Jiang L; Gaw TE; Kaydo LN; Richard ZC; O'Neil MF; Pritchard MT
Biomolecules; 2016 Jan; 6(1):5. PubMed ID: 26751492
[TBL] [Abstract][Full Text] [Related]
8. Adenosine 2A receptor antagonist prevented and reversed liver fibrosis in a mouse model of ethanol-exacerbated liver fibrosis.
Chiang DJ; Roychowdhury S; Bush K; McMullen MR; Pisano S; Niese K; Olman MA; Pritchard MT; Nagy LE
PLoS One; 2013; 8(7):e69114. PubMed ID: 23874883
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Hyaluronan synthase 2 suppresses liver fibrosis in mice via induction of transcriptomic changes similar to 4MU treatment.
Halimani N; Nesterchuk M; Tsitrina AA; Sabirov M; Andreichenko IN; Dashenkova NO; Petrova E; Kulikov AM; Zatsepin TS; Romanov RA; Mikaelyan AS; Kotelevtsev YV
Sci Rep; 2024 Feb; 14(1):2797. PubMed ID: 38307876
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of serum extracellular vesicles in liver fibrosis.
Chen L; Chen R; Kemper S; Cong M; You H; Brigstock DR
J Extracell Vesicles; 2018; 7(1):1461505. PubMed ID: 29696080
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of hyaluronan synthase 3 deficiency after acute vs chronic liver injury in mice.
McCracken JM; Jiang L; Deshpande KT; O'Neil MF; Pritchard MT
Fibrogenesis Tissue Repair; 2016; 9():4. PubMed ID: 27042213
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of hyaluronan synthesis protects against central nervous system (CNS) autoimmunity and increases CXCL12 expression in the inflamed CNS.
Mueller AM; Yoon BH; Sadiq SA
J Biol Chem; 2014 Aug; 289(33):22888-22899. PubMed ID: 24973214
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-inducible gene 6 protein and its derived peptide ameliorate liver fibrosis by repressing CD44 activation in mice with alcohol-related liver disease.
Han J; Lee C; Jeong H; Jeon S; Lee M; Lee H; Choi YH; Jung Y
J Biomed Sci; 2024 May; 31(1):54. PubMed ID: 38790021
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway.
Ishida K; Kaji K; Sato S; Ogawa H; Takagi H; Takaya H; Kawaratani H; Moriya K; Namisaki T; Akahane T; Yoshiji H
J Nutr Biochem; 2021 Mar; 89():108573. PubMed ID: 33388347
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.
Seth D; Duly A; Kuo PC; McCaughan GW; Haber PS
World J Gastroenterol; 2014 Sep; 20(36):13088-104. PubMed ID: 25278703
[TBL] [Abstract][Full Text] [Related]
17. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Losartan-Loaded Hyaluronic Acid (HA) Micelles for the Reduction of Advanced Hepatic Fibrosis in C3H/HeN Mice Model.
Thomas RG; Moon MJ; Kim JH; Lee JH; Jeong YY
PLoS One; 2015; 10(12):e0145512. PubMed ID: 26714035
[TBL] [Abstract][Full Text] [Related]
19. Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.
Bárcena C; Stefanovic M; Tutusaus A; Joannas L; Menéndez A; García-Ruiz C; Sancho-Bru P; Marí M; Caballeria J; Rothlin CV; Fernández-Checa JC; de Frutos PG; Morales A
J Hepatol; 2015 Sep; 63(3):670-8. PubMed ID: 25908269
[TBL] [Abstract][Full Text] [Related]
20. Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis During Alcohol-Induced Injury.
Brandon-Warner E; Feilen NA; Culberson CR; Field CO; deLemos AS; Russo MW; Schrum LW
Alcohol Clin Exp Res; 2016 Jul; 40(7):1430-42. PubMed ID: 27291156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
